Cargando…
Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells
Inflammation constitutes an important component of non-alcoholic fatty liver disease. STAT3 is a direct target of inflammatory cytokines, but also mediates glycolipid metabolism in the liver. As a potent inhibitor of STAT3, the effect of Nifuroxazide (Nifu) on glycolipid metabolism in liver has not...
Autores principales: | Liu, Jing-Yi, Zhang, Yi-Chen, Song, Li-Ni, Zhang, Lin, Yang, Fang-Yuan, Zhu, Xiao-Rong, Cheng, Zhi-Qiang, Cao, Xi, Yang, Jin-Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076084/ https://www.ncbi.nlm.nih.gov/pubmed/35540668 http://dx.doi.org/10.1039/c9ra06527j |
Ejemplares similares
-
Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells
por: Luo, Xiaoqin, et al.
Publicado: (2012) -
Differential Lipid Accumulation on HepG2 Cells Triggered by Palmitic and Linoleic Fatty Acids Exposure
por: Teixeira, Francisca S., et al.
Publicado: (2023) -
Effect of Carotenoids from Phaeodactylum tricornutum on Palmitate-Treated HepG2 Cells
por: Mayer, Claire, et al.
Publicado: (2020) -
Involvement of Endoplasmic Reticulum Stress in Palmitate-induced Apoptosis in HepG2 Cells
por: Cho, Hyang-Ki, et al.
Publicado: (2008) -
Repression of PKR Mediates Palmitate-Induced Apoptosis in HepG2 Cells through Bcl-2
por: Yang, Xuerui, et al.
Publicado: (2009)